AquaGene has developed proprietary technologies to manufacture biologically active, therapeutic proteins in genetically engineered, or transgenic, fish. A transgenic organism is created by introducing a foreign gene into the organism’s genome using a variety of recombinant DNA techniques. The new gene, which provides instructions to make a specific protein, will be passed on to the organism’s offspring. The company’s strategy is to manufacture and market, in partnership with suitable pharmaceutical companies, proteins with significant commercial potential for either human or veterinary medical applications. The company’s first product is human Factor VII, a blood-clotting protein used to treat hemophilia.
Fortress provides leading hardware and software products to ensure secure communications. The Company’s core technology, Secure Packet Shield, is a patented system of network-layer data encryption, data compression, user authentication, and data integrity assurance. Fortress products are designed for use in Virtual Private Network and cable modem architecture. Co-investors are Sutro Venture Partners and c-Corn.net.
Image-Guided Neurologics has developed proprietary devices and procedural methods that will allow for new and improved treatment of patients who suffer from serious neurological diseases. The company’s products are designed to work with imaging technologies, primarily MRI, allowing direct and remote MR-guided placement of therapeutic modalities into the brain. The IGN products will also allow MR-visualization of the therapy, including neurostimulation and other therapeutic interventions, cell transplantation and drug distribution.
The company was sold to Medtronic (NYSE: MDT) in 2005.
Patriot Risk Management
Ft. Lauderdale, Florida
Patriot Risk Management (PRMI) is a workers’ compensation insurance services company that was founded in 2003. PRMI provides claims management, nurse case management, cost containment, subrogation recovery, fraud investigation and management services to insurance companies, reinsurers and segregated portfolio captives.